Kathleen Goin, Chief Operating Officer at PALVELLA THERAPEUTICS, INC. (PVLA), sold 4,302 shares at $110.35 ($476K) on 2026-05-20, disclosed to the SEC on 2026-05-22.
Scheduled sale ($476k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $110.35 | 3,363 | $371K | 78.0% |
| 2 | $111.30 | 891 | $99K | 20.8% |
| 3 | $111.89 | 48 | $5K | 1.1% |
| Total | $110.56 avg | 4,302 | $476K | 100% |
| Filing → |
| PVLA | SELL | 2026-07-17 | $642K | — | Filing → |
| PVLA | SELL | 2026-06-22 | $476K | — | Filing → |
| PVLA | SELL | 2026-04-17 | $547K | — | Filing → |